- Open
- 5.75
- High
- 6.00
- Low
- 5.50
- Close
- 6.00
- Change
- -0.25 (-4.35%)
- Volume
- 257,082
| 26 Jun 2026 | 15:00:01 | Investor presentation and Q&A |
| 23 Jun 2026 | 16:25:00 | Result of AGM |
| 2 Jun 2026 | 07:00:06 | Investor presentation and SweetBiotix® Sampling |
| 29 May 2026 | 07:00:04 | Director/PDMR Shareholding |
| 28 May 2026 | 07:00:03 | Final Results & Notice of AGM |
| 4 Jul 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
OptiBiotix Health plc is a life sciences company focused on developing products aimed at improving health through the gut microbiome. Its primary offerings include SlimBiome®, a weight management product that reduces hunger and cravings, and WellBiome®, a prebiotic fiber complex that enhances gut health and supports overall wellbeing. The company also develops SweetBiotix®, a natural sugar substitute, and microbiome modulators for various health applications. OptiBiotix operates globally, targeting consumers seeking healthier lifestyle choices and partners in the nutraceutical and pharmaceutical sectors.
| 26 Jun 2026 | 15:00:01 | Investor presentation and Q&A |
| 23 Jun 2026 | 16:25:00 | Result of AGM |
| 2 Jun 2026 | 07:00:06 | Investor presentation and SweetBiotix® Sampling |
| 29 May 2026 | 07:00:04 | Director/PDMR Shareholding |
| 28 May 2026 | 07:00:03 | Final Results & Notice of AGM |
| 4 Jul 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
OptiBiotix Health plc is a life sciences company focused on developing products aimed at improving health through the gut microbiome. Its primary offerings include SlimBiome®, a weight management product that reduces hunger and cravings, and WellBiome®, a prebiotic fiber complex that enhances gut health and supports overall wellbeing. The company also develops SweetBiotix®, a natural sugar substitute, and microbiome modulators for various health applications. OptiBiotix operates globally, targeting consumers seeking healthier lifestyle choices and partners in the nutraceutical and pharmaceutical sectors.
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.12bn | -0.4% | |
| £123m | +0.1% | |
| £13m | -0.0% | |
| £12m | +1.4% | |
| £10m | +0.3% | |
OPTIOptibiotix Health PLC | £6m | -0.5% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £1.12bn | -0.4% | |
| £123m | +0.1% | |
| £13m | -0.0% | |
| £12m | +1.4% | |
| £10m | +0.3% | |
OPTIOptibiotix Health PLC | £6m | -0.5% |